Form 4: NovAccess Global Inc. Director John Cassarini Acquires Convertible Loan
SEC Form 4 Filing
Director John Cassarini reports acquiring a $9,000 convertible loan in NovAccess Global Inc. on May 31, 2024, convertible to common stock at $0.11 per share.
Summary
- John Cassarini, a director of NovAccess Global Inc., filed a Form 4 on June 4, 2024, reporting a transaction.
- On May 31, 2024, Mr. Cassarini acquired a convertible loan from NovAccess Global Inc. for $9,000.
- The loan is convertible into the company's common stock at a price of $0.11 per share.
- The loan is convertible until it is paid in full.
- The conversion results in 81,818 shares of common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral. It simply reports a transaction.
Management Comments
- Mr. Cassarini loaned NovAccess $9,000 on May 31, 2024.
- The loan is convertible into shares of the company's common stock at $0.11 a share.
Industry Context
This filing is a routine disclosure of insider activity, required by the SEC to ensure transparency and prevent insider trading. It provides insight into the actions of company directors.
Related Party Transactions
- John Cassarini, a director, provided a $9,000 convertible loan to NovAccess Global Inc.
Stakeholder Impact
- The conversion of the loan will result in dilution for existing shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/31/2024 | Date of convertible loan transaction |
| 06/04/2024 | Date Form 4 was signed |
Keywords
Form 4, insider trading, convertible loan, beneficial ownership, XSNX, NovAccess Global Inc., Cassarini, director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.